rs145666414
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000375401.8(KDM5C):āc.4597A>Cā(p.Thr1533Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000898 in 1,203,148 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 25 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
ENST00000375401.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KDM5C | NM_004187.5 | c.4597A>C | p.Thr1533Pro | missense_variant | 26/26 | ENST00000375401.8 | NP_004178.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KDM5C | ENST00000375401.8 | c.4597A>C | p.Thr1533Pro | missense_variant | 26/26 | 1 | NM_004187.5 | ENSP00000364550 | P5 |
Frequencies
GnomAD3 genomes AF: 0.000485 AC: 53AN: 109379Hom.: 0 Cov.: 20 AF XY: 0.000409 AC XY: 13AN XY: 31755
GnomAD3 exomes AF: 0.000140 AC: 24AN: 171750Hom.: 0 AF XY: 0.0000687 AC XY: 4AN XY: 58202
GnomAD4 exome AF: 0.0000503 AC: 55AN: 1093769Hom.: 0 Cov.: 33 AF XY: 0.0000334 AC XY: 12AN XY: 359643
GnomAD4 genome AF: 0.000485 AC: 53AN: 109379Hom.: 0 Cov.: 20 AF XY: 0.000409 AC XY: 13AN XY: 31755
ClinVar
Submissions by phenotype
Spastic paraplegia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 22, 2023 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 02, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 26, 2020 | - - |
not specified Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at